title: Docosatetraenoic acid in endothelial cells: formation, retroconversion to arachidonic acid, and effect on prostacyclin production.
abstract: Cultured bovine aortic endothelial cells convert arachidonic acid to docosatetraenoic acid and also take up docosatetraenoic acid from the extracellular fluid. After a 24-h incubation with biosynthetically prepared [3H]docosatetraenoic acid, about 20% of the cellular fatty acid radioactivity was converted to arachidonic acid. Furthermore, in pulse-chase experiments, the decrease in phospholipid docosatetraenoic acid content was accompanied by an increase in arachidonic acid, providing additional evidence for retroconversion. These findings suggest that one possible function of docosatetraenoic acid in endothelial cells is to serve as a source of arachidonic acid. The endothelial cells can release docosatetraenoic acid when they are stimulated with ionophore A23187, but they do not form appreciable amounts of eicosanoids from docosatetraenoic acid. Enrichment of the endothelial cells with docosatetraenoic acid reduced their capacity to produce prostacyclin (PGI2) in response to ionophore A23187. This may be related to the fact that docosatetraenoic acid enrichment caused a 40% reduction in the arachidonic acid content of the inositol phosphoglycerides. In addition, less prostacyclin was formed when the enriched cells were incubated with arachidonic acid, suggesting that docosatetraenoic acid also may act as an inhibitor of prostaglandin synthesis in endothelial cells.
authors.forename: C J
authors.initials: CJ
authors.lastname: Mann
authors.forename: T L
authors.initials: TL
authors.lastname: Kaduce
authors.forename: P H
authors.initials: PH
authors.lastname: Figard
authors.forename: A A
authors.initials: AA
authors.lastname: Spector
mesh_terms: D000818:Animals; D001011:Aorta / Q000378:metabolism; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism*; D000001:Calcimycin / Q000494:pharmacology; D002250:Carbon Radioisotopes; D002417:Cattle; D002478:Cells, Cultured; D004727:Endothelium / Q000378:metabolism*; D011464:Epoprostenol / Q000096:biosynthesis*; D004883:Erucic Acids / Q000378:metabolism* / Q000494:pharmacology; D005227:Fatty Acids / Q000032:analysis / Q000378:metabolism; D005231:Fatty Acids, Unsaturated / Q000378:metabolism*; D010743:Phospholipids / Q000032:analysis / Q000378:metabolism; D014280:Triglycerides / Q000378:metabolism; D014316:Tritium
chemical_list: D001095:Arachidonic Acids; D002250:Carbon Radioisotopes; D004883:Erucic Acids; D005227:Fatty Acids; D005231:Fatty Acids, Unsaturated; D010743:Phospholipids; D014280:Triglycerides; D014316:Tritium; C011395:adrenic acid; D016718:Arachidonic Acid; D000001:Calcimycin; D011464:Epoprostenol